The present invention relates to Bub1 kinase (= Budding uninhibited by benzimidazole kinase) inhibiting 1-(pyrimidin-2-yl)-1H-indazole compounds of formula (I), i.e. which therefore have potential to treat hyperprofilerative diseases such as cancer.
本发明涉及公害1激酶(=不受
苯并咪唑抑制的发芽激酶)
抑制剂1-(
嘧啶-2-基)-1H-
吲唑化合物的公式(I),即因此具有潜力治疗癌症等过度增殖性疾病。